GlaxoSmithKline says it plans to use the UK's upcoming 10-percent "patent box" tax break to scale up current manufacturing and build "a significant new plant." It says it will also develop technology in what may turn out to be the windfall that the UK government is hoping for, with the promise of 1,000 jobs. Article